Research project

DAME: Treatment of >400μ central-involving Diabetic macular oedema with fAricimab versus combined Faricimab and subthreshold Micropulse lasEr (SML) applied when central retinal thickness is reduced below 400μ (DAME): A randomised clinical trial.

Staff

Lead researchers

Professor Andrew Lotery

Professor of Ophthalmology

Research interests

  • Ocular clinical trials
  • Age related macular degeneration
  • Central serous chorioretinopathy
Connect with Andrew

Research outputs